ATORVASTATIN CALCIUM
- Product NDC
- 68788-7631
- 11-digit product format
- 687887631
- Labeler code
- 68788
- Product ID
- 68788-7631_50966f72-47ab-4c76-aa51-228a58e361eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA207687
- Marketing category
- ANDA
- Marketing start
- 2020-03-05
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7631-1 | 68788763101 | 100 TABLET, FILM COATED in 1 BOTTLE (68788-7631-1) | 2020-03-05 | 0000-00-00 | No | No | Current |
| 68788-7631-3 | 68788763103 | 30 TABLET, FILM COATED in 1 BOTTLE (68788-7631-3) | 2020-03-05 | 0000-00-00 | No | No | Current |
| 68788-7631-6 | 68788763106 | 60 TABLET, FILM COATED in 1 BOTTLE (68788-7631-6) | 2020-03-05 | 0000-00-00 | No | No | Current |
| 68788-7631-9 | 68788763109 | 90 TABLET, FILM COATED in 1 BOTTLE (68788-7631-9) | 2020-03-05 | 0000-00-00 | No | No | Current |